Picropodophyllin, an IGF‑1 receptor inhibitor, enhances oxaliplatin efficacy in chemoresistant colorectal cancer HCT116 cells by reducing metastatic potential. [PDF]
Kayacik N +4 more
europepmc +1 more source
Generation of Oxaliplatin Resistant HCT116 Colorectal Cancer Cell Sublines, with Reduced miR-23b and miR-27b miRNA Expression, Using CRISPR-Cas9 System Clinical and in vitro experiments show that Oxa/HCT116 colorectal cancer cells resistant to ...
Maželis, Ignas,
core
Effects of histone deacetylase inhibitors on ATP-binding cassette transporters in lung cancer A549 and colorectal cancer HCT116 cells. [PDF]
Wang H +5 more
europepmc +1 more source
The practice of traditional medicine for cancer treatment and prevention is rising since the last decades. Clinacanthus nutans (Burm.f.) Lindau had been used traditionally for the treatment of inflammation, insect bites, snake bites, diabetes, herpes ...
Wang, Kar Suen
core
Effect of serum starvation on secretion of exosomes in colorectal cancer HCT116 cells
openaire +1 more source
Antiproliferative effect of new chalcone derivatives in human colorectal cancer HCT116 cells
Mojzisova, Gabriela +7 more
openaire +2 more sources
Low-energy spontaneous fabrication of quercetin-loaded orange oil nanoemulsion for induction of colorectal cancer cell apoptosis. [PDF]
Abd-Rabou AA, Edris AE.
europepmc +1 more source
PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation. [PDF]
Li W +17 more
europepmc +1 more source
HERC4 suppresses colorectal cancer progression by promoting STAT3 ubiquitination. [PDF]
Jiang L +9 more
europepmc +1 more source
Phytate, myo-inositol hexaphosphate (IP6), has been shown to possess anti-carcinogenic qualities. IP6 appears to be partially digested in the digestive tract and degraded into inositol di, tri-, and tetra-phosphate (IP2, IP3, and IP4). The present study investigated whether IP3-rich phytate hydrolysate (IP3-RPH), a partially degraded product from ...
openaire

